Transplanted Organ Rejection clinical trials at UCSF
1 research study open to eligible people
A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation
open to eligible people ages 18 years and up
A randomized controlled study to assess the safety and efficacy and overall benefit of FCR001 cell therapy in de novo living donor renal transplantation.
San Francisco, California and other locations